Maureen Trudeau

18.8k citations
225 papers · 14.6k · 5 hit papers · h-index 54

Impact in

    • Breast Cancer Treatment Studies
    • Cancer Genomics and Diagnostics
  • Oncology top 0.2%
    • HER2/EGFR in Cancer Research
    • Cancer Risks and Factors
    • Cancer Treatment and Pharmacology
    • Cancer Cells and Metastasis

Papers in

    • Breast Cancer Treatment Studies 64
    • HER2/EGFR in Cancer Research 32
    • Cancer Treatment and Pharmacology 21
    • Global Cancer Incidence and Screening 12

Maureen Trudeau

221 papers receiving 14.1k citations

Maureen Trudeau's Hit Papers

Neratinib Plus Capecitabine Versus Lapatinib Plus Capecitabine in HER2-Positive Metastatic Breast Cancer Previously Treated With ≥ 2 HER2-Directed Regimens: Phase III NALA Trial 2020 · 482 citations
4820+6+12Years since publication10002.0k3.0k4.0k

Peers

Maureen Trudeau
Comparison fields: 5 of 165
  • Cancer Research 4.3k
  • Oncology 6.2k
  • Pulmonary and Respiratory Medicine 1.9k
  • Radiology, Nuclear Medicine and Imaging 1.4k
  • Pathology and Forensic Medicine 820
Replace Paul Kelly Marcom with:
Paul Kelly Marcom United States
Rebecca Alexandra Dent Singapore
Dino Amadori Italy
Elsken van der Wall Netherlands
Fabio Puglisi Italy
Sabino De Placido Italy
David G. Hicks United States
Alberto Ocaña Spain
Anna Maria Storniolo United States
Vivianne C. G. Tjan‐Heijnen Netherlands
Maureen Trudeau relative to Paul Kelly Marcom United States Paul Kelly Marcom's profile →
Citations per field
00.5×1.5×
Paul Kelly Marcom · 1×
Citations per year

Countries citing papers authored by Maureen Trudeau

Since Specialization
Citations

This map shows the geographic impact of Maureen Trudeau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maureen Trudeau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maureen Trudeau more than expected).

Fields of papers citing papers by Maureen Trudeau

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maureen Trudeau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maureen Trudeau. The network helps show where Maureen Trudeau may publish in the future.

Co-authors

The 25 scholars most cited alongside Maureen Trudeau, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Maureen Trudeau Line = papers co-authored together Maureen Trudeau links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 225 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Triple-Negative Breast Cancer: Clinical Features and Patterns of Recurrence
Hit paper breakdown →
20074069
2 2002575
3 2004513
4
Blood-Brain Barrier Opening in Primary Brain Tumors with Non-invasive MR-Guided Focused Ultrasound: A Clinical Safety and Feasibility Study
Hit paper breakdown →
2019512
5
Neratinib Plus Capecitabine Versus Lapatinib Plus Capecitabine in HER2-Positive Metastatic Breast Cancer Previously Treated With ≥ 2 HER2-Directed Regimens: Phase III NALA Trial
Hit paper breakdown →
2020482
6 1999467
7
Pattern of metastatic spread in triple-negative breast cancer
Hit paper breakdown →
2008460
8
Enzalutamide for the Treatment of Androgen Receptor–Expressing Triple-Negative Breast Cancer
Hit paper breakdown →
2018396
9 1999266
10 2012221
11 2011170
12 2021166
13 2008163
14 2008147
15 2000130
16 2018120
17 2006118
18 2005113
19 2016113
20 2005112

About Maureen Trudeau

Maureen Trudeau is a scholar working on Cancer Research, Oncology, Radiology, Nuclear Medicine and Imaging, Economics and Econometrics and Genetics, having authored 225 papers that have together received 14.6k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (64 papers), HER2/EGFR in Cancer Research (32 papers), Cancer Treatment and Pharmacology (21 papers), Economic and Financial Impacts of Cancer (14 papers), Health Systems, Economic Evaluations, Quality of Life (14 papers), Estrogen and related hormone effects (12 papers), Global Cancer Incidence and Screening (12 papers) and Radiomics and Machine Learning in Medical Imaging (10 papers). The work is most often cited by research in Cancer Research (4.3k citations), Oncology (6.2k citations), Pulmonary and Respiratory Medicine (1.9k citations), Radiology, Nuclear Medicine and Imaging (1.4k citations) and Pathology and Forensic Medicine (820 citations). Maureen Trudeau has collaborated with scholars based in Canada, United States and United Kingdom. Frequent co-authors include Kathleen Pritchard, Wedad M. Hanna, Steven Alexander Narod, Rebecca Alexandra Dent, Ping Sun, Ellen Rawlinson, Carol Anne Sawka, Lavina A. Lickley, Nicky Hood and Marguerite Ennis. Their work appears in journals such as Journal of Clinical Oncology, Breast Cancer Research and Treatment, Oncotarget, Cancer and Annals of Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact